HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 18-20 | Hybrid Event

September 18-20, 2025 | London, UK

Pharmaceutical Biotechnology & Drug Discovery

Pharmaceutical Biotechnology & Drug Discovery

Reimagining the landscape of therapeutic innovation, pharmaceutical biotechnology & drug discovery leverages molecular biology, genomics, and cell culture systems to create next-generation biopharmaceuticals. Monoclonal antibodies, recombinant proteins, and RNA-based therapies are now pivotal in treating complex diseases, including cancer and autoimmune disorders. High-throughput screening, structure-based drug design, and bioinformatics platforms expedite the identification of potent drug candidates. In Pharmaceutical Biotechnology & Drug Discovery, personalized medicine is also gaining traction through biomarkers and companion diagnostics, enabling tailored treatments. Furthermore, biotechnology enhances drug delivery via nanocarriers and controlled-release systems, improving efficacy and patient compliance. This evolving field plays a central role in shaping modern healthcare, offering precision, safety, and scalability in therapeutic development.

Committee Members
Speaker at Biotechnology and Bioengineering 2025 - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Biotechnology and Bioengineering 2025 - Steve Busby

Steve Busby

University of Birmingham, United Kingdom
Speaker at Biotechnology and Bioengineering 2025 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
ECBB 2025 Speakers
Speaker at Biotechnology and Bioengineering 2025 - Julia Sidorova

Julia Sidorova

Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Speaker at Biotechnology and Bioengineering 2025 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Speaker at Biotechnology and Bioengineering 2025 - Assad Al Ammar

Assad Al Ammar

Specialty Enzymes and Probiotics, United States
Speaker at Biotechnology and Bioengineering 2025 - Tina Moller Tagmose

Tina Moller Tagmose

Novo Nordisk A/S, Denmark
Tags

Submit your abstract Today

Watsapp
a